CDCP1 Expression Is a Potential Biomarker of Poor Prognosis in Resected Stage I Non-Small-Cell Lung Cancer.

J Clin Med · 2022 · PMC8779436 · PMID 35054034

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

an increasing trendp < 0.001actually significant

Risk Factor Analysis of 5-Year Survival after Surgery The 5-year overall survival (OS) of all patients was 69.3%, and the mortality rate showed an increasing trend according to the stage ( p < 0.001).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.